Trade Mark Journal No.2026/030 24 July 2026

UK00004415205 13 July 2026 (5)

SENDOLOR

Class 5: Pharmaceutical preparations for the treatment of severe acute pain, cancer pain and breakthrough cancer pain. .

Mperium B.V.

Representative: Elkington and Fife LLP